Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B Cell Lymphoma (DLBCL)

Explore clinical trials studying Diffuse Large B Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.

37 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B Cell Lymphoma (DLBCL) trial results

Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

NCT04450069

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

NCT01148446

Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Elderly Patients (>65 Years), Hemic and Lymphatic Diseases, +10 more
Locations
  • S.C. di Ematologia, Spedali Civili Brescia, Italy
  • Ospedale di Vigevano Vigevano, Pavia, Italy
  • Ospedale Garibaldi-Nesima Catania, Italy
  • Ospedale civile Divisione di Ematologia Civitanova Marche (MC), Italy
View Trial Details

Related conditions